Total oxidative stress and antioxidant status in patients with carpal tunnel syndrome

Redox Report

Volumn 17, Issue 6, 2012, Pages 234-238

  Demirkol, Ahmet ^a   Uludag, Murat ^b   Soran, Neslihan ^a   Aksoy, Nurten ^a   Gun, Kerem ^c   Incebiyik, Serap ^a   Gurgen, Ismahan ^a   Vural, Mehmet ^a   Altun, Yaşar ^a   Kesiktas, Fatma Nur ^c  

^a HARRAN UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c Balikligol State Hospital   (Turkey)

Author keywords

Antioxidant status; Carpal tunnel syndrome; Oxidative stress index; Pathogenesis; Total oxidative stress

Indexed keywords

ADULT; AGED; ARTICLE; CARPAL TUNNEL SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; ELECTROPHYSIOLOGY; FEMALE; HEMATOLOGICAL PARAMETERS; HUMAN; HUMAN TISSUE; LATENT PERIOD; MALE; MUSCLE STRENGTH; NERVE CONDUCTION; OXIDATIVE STRESS; PRIORITY JOURNAL; RANGE OF MOTION; TOTAL ANTIOXIDANT STATUS;

TOSCANA VIRUS;

EID: 84871873827     PISSN: 13510002     EISSN: 17432928     Source Type: Journal    
DOI: 10.1179/1351000212Y.0000000027     Document Type: Article

References (26)

1. Boland RA, Kiernan MC. Assessing the accuracy of a combination of clinical tests for identifying carpal tunnel syndrome. J Clin Neurosci 2009;16:929-33.
2. Talmor M, Patel MP, Spann MD, Barden C, Specht M, McLean A, et al. COX-2 up-regulation in idiopathic carpal tunnel syndrome. Plast Reconstr Surg 2003;112:1807-14.
3. Bland JD. Carpal tunnel syndrome. Curr Opin Neurol 2005;18: 581-5.
4. Ettema AM, Amadio PC, Zhao C, Wold LE, O'Byrne MM, Moran SL, et al. Changes in the functional structure of the tenosynovium in idiopathic carpal tunnel syndrome: a scanning electron microscope study. Plast Reconstr Surg 2006;118: 1413-22.
5. Sud V, Freeland AE. Biochemistry of carpal tunnel syndrome Microsurgery 2005;25(1):44-6
6. Karakoc M, Altindag O, Keles H, Soran N, Selek S. Serum oxidative-antioxidative status in patients with ankylosing spondilitis. Rheumatol Int 2007;27:1131-4.
7. Freeland AE, Tucci MA, Barbieri RA, Angel MF, Nick T. Biochemical evaluation of serum and flexor tenosynovium in carpal tunnel syndrome. Microsurgery 2002;22:378-85.
8. Levine DW, Simmons BP, Koris MJ, Daltroy LH, Hohl GG, Fossel AH, et al. A self-administered questionnaire for the assessment of severity of symptoms and functional status in carpal tunnel syndrome. J Bone Joint Surg Am 1993;75:1585-92.
9. Sezgin M, Incel NA, Serhan S, Camdeviren H, As I, Erdogan C. Assessment of symptom severity and functional status in patients with carpal tunnel syndrome: reliability and functionality of the Turkish version of the Boston Questionnaire. Disabil Rehabil 2006;28:1281-5.
10. Kaymak B, Ozçakar L, Cetin A, Candan Cetin M, Akinci A, Hasçelik Z. A comparison of the benefits of sonography and electrophysiologic measurements as predictors of symptom severity and functional status in patients with carpal tunnel syndrome. Arch Phys Med Rehabil 2008;89:743-8.
11. Karadag O, Kalyoncu U, Akdogan A, Karadag YS, Bilgen SA, Ozbakir S,et al. Sonographic assessment of carpal tunnel syndrome in rheumatoid arthritis: prevalence and correlation with disease activity. Rheumatol Int 2012;32:2313-9.
12. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004;37:112-9.
13. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005;38:1103-11.
14. Hirata H, Nagakura T, Tsujii M, Morita A, Fujisawa K, Uchida A. The relationship of VEGF and PGE2 expression to extracellular matrix remodelling of the tenosynovium in the carpal tunnel syndrome. J Pathol 2004;204:605-12.
15. Hirata H, Tsujii M, Yoshida T, Imanaka-Yoshida K, Morita A, Okuyama N, et al. MMP-2 expression is associated with rapidly proliferative arteriosclerosis in the flexor tenosynovium and pain severity in carpal tunnel syndrome. J Pathol 2005;205:443-50.
16. Padua L, Padua R, Aprile I, D'Amico P, Tonali P. Carpal tunnel syndrome: relationship between clinical and patient-oriented assessment. Clin Orthop 2002;395:128-34.
17. Day BJ. Antioxidants as potential therapeutics for lung fibrosis. Antioxid Redox Signal 2008;10:355-70.
18. Hitchon CA, El-Gabalawy HS. Oxidation in rheumatoid arthritis. Arthr Res Ther 2004;6:265-78.
19. Yazici C, Kose K, Calis M, Kuzuguden S, Kirnap M. Protein oxidation status in patients with ankylosing spondylitis. Rheumatology (Oxford) 2004;43:1235-9.
20. Mungan AG, Can M, Acikgoz S, Esturk E, Altinyazar C. Lipid peroxidation and homocysteine levels in Behcet's disease. Clin Chem Lab Med 2006;44:1115-8.
21. Barbe MF, Barr AE. Inflammation and the pathophysiology of work-related musculoskeletal disorders. Brain Behav Immun 2006;20:423-9.
22. Fearon IM, Faux SP. Oxidative stress and cardiovascular disease: novel tools give (free) radical insight. J Mol Cell Cardiol 2009;47:372-81.
23. Lee R, Margaritis M, Channon KM, Antoniades C. Evaluating oxidative stress in human cardiovascular disease: methodological aspects and considerations. Curr Med Chem 2012;19:2504-20.
24. Tamer L, Sucu N, Polat G, Ercan B, Aytacoglu B, Yücebilgiç G, et al. Decreased serum total antioxidant status and erythrocytereduced glutathione levels are associated with increased serum malondialdehyde in atherosclerotic patients. Arch Med Res 2002;33:257-60.
25. Yagi K. Lipid peroxides and related radicals in clinical medicine. In: Armstrong D., (ed.). Free radicals in diagnostic medicine. New York: Plenum Press; 1994. p. 1-15.
26. Shiri R, Heliövaara M, Moilanen L, Viikari J, Liira H, Viikari-Juntura E. Associations of cardiovascular risk factors, carotid intima-media thickness and manifest atherosclerotic vascular disease with carpal tunnel syndrome. BMC Musculoskelet Disord 2011;12:80.